Literature DB >> 8170956

Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice.

O Smithies1, H S Kim.   

Abstract

Experimental analysis of complex quantitative genetic traits, such as essential hypertension, should be greatly facilitated by being able to manipulate the expression of a gene in living animals without altering the nucleotide sequence, chromosomal location, or regulatory elements of the gene. To explore this possibility, we have used targeted gene disruption and duplication to generate mice that are genetically identical [(129 x C57BL6)F1] except for having one, two, or three functional copies of the gene coding for angiotensinogen. The two-copy animals have two normal copies of the angiotensinogen gene; the one-copy and three-copy animals have one normal copy with the other either disrupted or duplicated by gene targeting. The duplicated pair of genes was generated by a special form of gap-repair gene targeting that tandemly duplicates the whole of a gene together with 5' and 3' flanking regions. We find progressively and significantly higher levels of the gene product in the animals having increasing numbers of gene copies: the one-copy animals have steady-state plasma angiotensinogen levels approximately 35% of normal (P < 0.0001), and the three-copy animals have levels approximately 124% of normal (P < 0.004). Detailed information about regulatory sequences is not required for this type of experiment; nor is it necessary to have DNA clones or targeting constructs that cover the whole of the target gene. Varying gene copy numbers by targeting consequently offers a promising approach to quantitative genetics.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8170956      PMCID: PMC43630          DOI: 10.1073/pnas.91.9.3612

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

1.  Toward an animal model of cystic fibrosis: targeted interruption of exon 10 of the cystic fibrosis transmembrane regulator gene in embryonic stem cells.

Authors:  B H Koller; H S Kim; A M Latour; K Brigman; R C Boucher; P Scambler; B Wainwright; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

2.  Double-strand gap repair in a mammalian gene targeting reaction.

Authors:  V Valancius; O Smithies
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

3.  Recombinant fragment assay for gene targetting based on the polymerase chain reaction.

Authors:  H S Kim; O Smithies
Journal:  Nucleic Acids Res       Date:  1988-09-26       Impact factor: 16.971

4.  Efficient transformation and frequent single-site, single-copy insertion of DNA can be obtained in mouse erythroleukemia cells transformed by electroporation.

Authors:  S S Boggs; R G Gregg; N Borenstein; O Smithies
Journal:  Exp Hematol       Date:  1986-11       Impact factor: 3.084

5.  Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes.

Authors:  S L Mansour; K R Thomas; M R Capecchi
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

6.  Lambda Charon vectors (Ch32, 33, 34 and 35) adapted for DNA cloning in recombination-deficient hosts.

Authors:  W A Loenen; F R Blattner
Journal:  Gene       Date:  1983-12       Impact factor: 3.688

7.  Renin-angiotensin system in genetically hypertensive mice.

Authors:  H Iwao; N Nakamura; S Kim; F Ikemoto; K Yamamoto; G Schlager
Journal:  Jpn Circ J       Date:  1984-11

8.  Molecular basis of human hypertension: role of angiotensinogen.

Authors:  X Jeunemaitre; F Soubrier; Y V Kotelevtsev; R P Lifton; C S Williams; A Charru; S C Hunt; P N Hopkins; R R Williams; J M Lalouel
Journal:  Cell       Date:  1992-10-02       Impact factor: 41.582

9.  HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells.

Authors:  M Hooper; K Hardy; A Handyside; S Hunter; M Monk
Journal:  Nature       Date:  1987 Mar 19-25       Impact factor: 49.962

10.  Yeast transformation: a model system for the study of recombination.

Authors:  T L Orr-Weaver; J W Szostak; R J Rothstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

View more
  57 in total

1.  Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension.

Authors:  H Kobori; L M Harrison-Bernard; L G Navar
Journal:  Hypertension       Date:  2001-05       Impact factor: 10.190

2.  Mechanisms of double-strand-break repair during gene targeting in mammalian cells.

Authors:  P Ng; M D Baker
Journal:  Genetics       Date:  1999-03       Impact factor: 4.562

3.  Titrating angiotensinogen in salt sensitive hypertension.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2007-04       Impact factor: 4.599

4.  Contribution of a nuclear factor-kappaB binding site to human angiotensinogen promoter activity in renal proximal tubular cells.

Authors:  Omar W Acres; Ryousuke Satou; L Gabriel Navar; Hiroyuki Kobori
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

Review 5.  Renin-angiotensin-aldosterone system-mediated redox effects in chronic kidney disease.

Authors:  Ravi Nistala; Yongzhong Wei; James R Sowers; Adam Whaley-Connell
Journal:  Transl Res       Date:  2009-01-23       Impact factor: 7.012

6.  A growing chain of evidence linking genetic variation in angiotensinogen with essential hypertension: focus on "a haplotype of human angiotensinogen gene containing -217A increases blood pressure in transgenic mice compared with -217G," by Jain et al.

Authors:  Curt D Sigmund
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-10-29       Impact factor: 3.619

Review 7.  Inhibition of angiogenesis: a new function for angiotensinogen and des(angiotensin I)angiotensinogen.

Authors:  Pierre Corvol; Noel Lamandé; Amauri Cruz; Jerome Celerier; Jean-Marie Gasc
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

8.  Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.

Authors:  Hiroyuki Kobori; A Brent Alper; Rajesh Shenava; Akemi Katsurada; Toshie Saito; Naro Ohashi; Maki Urushihara; Kayoko Miyata; Ryousuke Satou; L Lee Hamm; L Gabriel Navar
Journal:  Hypertension       Date:  2008-12-15       Impact factor: 10.190

9.  Genetic control of blood pressure and the angiotensinogen locus.

Authors:  H S Kim; J H Krege; K D Kluckman; J R Hagaman; J B Hodgin; C F Best; J C Jennette; T M Coffman; N Maeda; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

10.  Natural selection and population history in the human angiotensinogen gene (AGT): 736 complete AGT sequences in chromosomes from around the world.

Authors:  Toshiaki Nakajima; Stephen Wooding; Takuro Sakagami; Mitsuru Emi; Katsushi Tokunaga; Gen Tamiya; Tomoaki Ishigami; Satoshi Umemura; Batmunkh Munkhbat; Feng Jin; Jia Guan-Jun; Ikuo Hayasaka; Takafumi Ishida; Naruya Saitou; Karel Pavelka; Jean-Marc Lalouel; Lynn B Jorde; Ituro Inoue
Journal:  Am J Hum Genet       Date:  2004-04-09       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.